Skip to Content

Tag: OMRON


Also Noted

OMRON receives OK from FDA

November 14, 2024HME News Staff

HOFFMAN ESTATES, Ill. – OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation detection. OMRON's novel machine learning IntelliSense AFib algorithm automatically analyzes the pressure pulse wave generated during blood pressure measurement to detect AFib, a leading cause of stroke. "OMRON Healthcare is making AFib screening a more integral part of our blood...

OMRON


Read Full Articlered right arrow icon